All Cardiometabolic disease articles – Page 2
-
NewsMetabolites produced in the intestine play a central role in controlling obesity and diabetes
A study has identified a group of metabolites that travel from the intestine to the liver and then to the heart, where they are pumped throughout the body. These metabolites play an important role in controlling metabolic pathways in the liver and insulin sensitivity.
-
NewsGut microbiome connects obesity to cancer, impacting public health
A new review highlights growing scientific evidence that imbalances in gut bacteria can influence metabolism, trigger inflammation, and increase cancer risk. These insights offer new possibilities for disease prevention, early detection, and personalized health care.
-
NewsNew study links gut microbes to common heart disease - suggesting ‘Jekyll and Hyde’ action
Researchers studying gut microbes recently identified 15 bacterial species associated with coronary artery disease. The analysis reveals multiple pathways linked to disease severity, including increased inflammation and metabolic imbalance.
-
NewsNot just a common cold: studies show RSV’s severity and impact on long-term health
Often confused for a common cold, respiratory syncytial virus (RSV) can in fact be serious and should be studied more closely. Researchers found that the illness could be of comparable severity to other more well-known respiratory viral infections (RVIs) – such as influenza and COVID-19.
-
NewsResearch finds higher rare risk of heart complications in children after COVID-19 infection than after vaccination
A whole-population study showed that although these conditions were rare, children and young people were more likely to experience heart, vascular or inflammatory problems after a COVID-19 infection than after having the vaccine — and the risks after infection lasted much longer.
-
NewsSome acute and chronic viral infections may increase the risk of cardiovascular disease
In the weeks following a bout of influenza or COVID, the risk of heart attack or stroke may rise dramatically, and chronic infections such as HIV may increase the long-term risk of serious cardiovascular disease events, according to new, independent research.
-
NewsGut microbiota disruption predicts severe steatosis in MASLD patients
A new study links gut dysbiosis with severe steatosis in metabolic dysfunction–associated steatotic liver disease (MASLD). In a 61-patient cohort, those with the inflammation-linked Bact2 enterotype developed severe steatosis at lower thresholds.
-
NewsMitochondria & microbiota: Targeting Extracellular Vesicles 2025 to explore game-changing pathways in medicine
The Second World Congress on Targeting Extracellular Vesicles (EVs) is scheduled for 15–16 October 2025 in Valencia, Spain. This event will spotlight the rapidly evolving science where mitochondrial biology and microbiome research intersect via extracellular vesicles.
-
NewsHeart rhythm disorder POTS common in patients with long COVID
A new study shows that an unusual heart rhythm disorder, POTS, is particularly common in people with long COVID. The majority of those affected are middle-aged women.
-
NewsTwo-drug combination shows promise in helping heal chronic wounds
By adding small doses of a simple molecule called chlorate to standard antibiotics, researchers foundthe combination proved 10,000 times more effective at killing bacterial cells in the lab than single-drug antibiotics.
-
NewsChristensenella tenuis inhibits gut-derived endotoxins to alleviate metabolic disorders
The gut probiotic Christensenella tenuis significantly alleviates endotoxemia and metabolic disorders by modulating gut bile acids (BAs) metabolism and suppressing lipopolysaccharide (LPS) translocation across the gut barrier, a new study finds.
-
NewsMajor report tackles Covid’s cardiovascular crisis head-on
Regular Covid vaccinations should continue worldwide to reduce cardiac risks associated with the virus - according to new research.
-
NewsType 2 diabetes may double risk of sepsis, large community-based study suggests
Living with type 2 diabetes (T2D) may double the risk of developing sepsis—with those aged younger than 60 years and men particularly susceptible, according to a long-term community-based study in Australia.
-
NewsYour genes could prune your gut bugs and protect you from disease
Researchers uncover genetic peptides that shape gut bacteria and protect against obesity and diabetes, revealing gut health is influenced by more than just diet and opening doors to personalised treatments.
-
NewsScientists report the first use of CRISPR activation to treat a cardiac disease in mice
Researchers have demonstrated for the first time that CRISPR-based gene activation (CRISPRa) can be used to treat genetic heart disease in vivo. The study paves the way for novel targeted therapies for patients with genetic cardiac disorders.
-
NewsGut microbiome influences proteins that drive aging and disease
Scientists have uncovered new associations between gut microbiome and the aging process. The researchers found that certain microbial characteristics may causally influence proteins in the blood linked to inflammation and heart health.
-
NewsRoutine Helicobacter pylori screening does not significantly reduce upper gastrointestinal bleeding in patients after a heart attack
Routine Helicobacter pylori screening did not significantly reduce the risk of upper gastrointestinal bleeding in patients hospitalised for myocardial infarction (MI), according to new research.
-
NewsConnection among gut fungi, genetics and disease risk in humans identified
A novel genome-wide association study sheds light on the human genetic determinants of the fungal component of the human microbiome and their relation to chronic disease.
-
NewsStudy suggests link between hepatitis B immunity and lower risk of developing diabetes
A research study shows that overall HBV immunity is linked with a 15% lower risk of diabetes, with higher protection in younger people and those with higher immunity shown by higher antibody levels.
-
NewsStudy finds significant health benefits from gut microbes transfer
A cohort of overweight teens who received fecal transfer eight years ago were found to have reduced risk for a series of metabolic changes which can lead to heart disease, stroke and diabetes, compared with the participants who received the placebo.